Clinical Trial Update: European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients [Phase 3]

View source ↗

Summary

An update on a Phase 3 European study of 3APS for mild-to-moderate Alzheimer's disease; the document does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• 3APS

Snippet

Sponsor: Bellus Health Inc. - a GSK company | Conditions: Alzheimer's Disease | Phase 3 | Status: UNKNOWN